Vis-Rx Prime Micro-Imaging Catheter Study

NCT ID: NCT06685783

Last Updated: 2025-04-29

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Total Enrollment: 70 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2024-12-11
• Study Completion Date: 2026-07-31

Brief Summary

To study the performance of the Gentuity® HF-OCT Imaging System and Vis-Rx Prime® Micro-Imaging Catheter when used to obtain images of coronary arteries in patients who are undergoing cardiac catheterization and are candidates for interventional procedures. The study will evaluate ease of catheter use by physicians using the catheters, image quality and overall performance. The patient's involvement in the study ends when the cardiac catheterization/interventional procedure is completed.

Detailed Description

This is a single arm, unblinded, multi-center, clinical evaluation that will be performed at 3 to 5 investigational sites in the United States with subjects who undergo HF-OCT imaging as part of their cardiac catheterization procedure. This study will evaluate a range of device operators (interventional cardiologists) as well as patients and vessels consistent with the product labeling. The operator evaluation will be determined post use of the device using a Likert Grading Scale. Clear Image Length of the acquired HF-OCT image will be measured by an independent core lab. Safety will be monitored through the interventional procedure and Adverse Events that are potentially related to either the device or the procedure will be recorded, evaluated and analyzed.

Conditions

Coronary Artery Disease

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Patients 18 years of age or older
• Patients willing and able to provide written informed consent to participate in evaluation
• Patients who are candidates for transluminal interventional procedures for their coronary arteries (also known as PCI)

Exclusion Criteria

• Bacteremia or sepsis
• Major coagulation system abnormalities
• Severe hemodynamic instability or shock
• Acute renal failure
• Disqualified for Coronary Artery Bypass Graft surgery
• Disqualified for Percutaneous Coronary Intervention
• Patients currently enrolled in another study to evaluate an investigational device or medication
• Any target vessel which has undergone a bypass procedure

• Total occlusion
• Coronary artery spasm
• Large thrombus (as visible under angiography)

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Gentuity, LLC

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Advocate Lutheran General Hospital

Park Ridge, Illinois, United States

St. Francis Hospital and Heart Center

Roslyn, New York, United States

Lindner Research Center at The Christ Hospital

Cincinnati, Ohio, United States

Countries

United States

Other Identifiers

MISC-074

Identifier Type: -

Identifier Source: org_study_id